160. Congenital ichthyosis Clinical trials / Disease details
Clinical trials : 36 / Drugs : 72 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 111
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01222000 (ClinicalTrials.gov) | October 2010 | 12/10/2010 | Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous | TREATMENT OF THE RECESSIVE NONBULLOUS CONGENITAL ICHTHYOSIS BY THE EPIGALLOCATECHINE CUTANEOUS | Lamellar Ichthyosis | Drug: apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side | Centre Hospitalier Universitaire de Nice | NULL | Not yet recruiting | 8 Years | N/A | Both | 8 | Phase 3 | France |
| 2 | EUCTR2009-013656-77-FR (EUCTR) | 15/10/2009 | 06/08/2009 | Traitment of recessive nonbullous congenital ichthyosis with topic Epigallocatechin. | Traitment of recessive nonbullous congenital ichthyosis with topic Epigallocatechin. | Recessive nonbullous congenital ichthyosis MedDRA version: 12.0;Level: HLT;Classification code 10021197;Term: Ichthyoses | Trade Name: VEREGEN(R) Product Name: VEREGEN(R) | Nice University Hospital | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 0 | France |